Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • IIPA seeks level...

    IIPA seeks level playing field for e-pharmacy space

    Written by savita thakur thakur Published On 2016-06-20T16:05:37+05:30  |  Updated On 20 Jun 2016 4:05 PM IST
    IIPA seeks level playing field for e-pharmacy space

    Mumbai : Seeking parity with offline players, the Indian Internet Pharmacy Association (IIPA) has urged the government to ensure an end to the "local level harassment" being faced by new entrepreneurs in the e-pharmacy space.


    "The IIPA is demanding a level field for all players in the e-pharmacy space, without favour or bias.


    "We seek clarity on guidelines to enable legitimate players to develop their business in this space and bring in the much needed innovation and technology driven transparency in this sector, leveraging best practices from across the world," IIPA President Prashant Tandon told here.


    "The model followed by IIPA members is fully compliant with the law. We have a digital platform governed by IT Act 2000, which transmits the prescription to an existing offline licensed pharmacy," he said.


    The e-pharmacy business model benefits consumers due to increased transparency, access, affordability and convenience.


    Additionally, the model holds tremendous promise for regulators to tackle the issues of fake medicines since the entire supply chain is well documented and tracked, which also ensures better pharma covigilance, or monitoring the effects of medical drugs after they have been licensed for use.


    Tandon said the debate has to be of "compliance vs non compliance" and not "online vs offline.


    "Any player that violates the law should be brought to book without favor or bias against one model against the other.


    "However, responsible and credible players who are making this sector better and transparent, such as members of IIPA, should not be harassed by uninformed local level inspectors," Tandon said.


    Expressing full faith in the government, Tandon said "local level harassment of e-pharmacy players should cease".


    The government should come out with an enabling environment for entrepreneurship and innovation to flourish in this space, which requires a lot of capital and technology to solve the many problems that have plagued this industry, he added.


    The Drug Controller General of India (DCGI) had earlier directed all the state/UT drug controllers to keep a strict watch on online sale of drugs and take action against violations of the Drugs and Cosmetics Rules.


    Tandon said the association supports all efforts to clamp down on violators and help clear misconceptions.


    IIPA pointed out that there are potentially multiple online pharmacies operating from different parts of the world that need to be monitored.


    In most countries, to fight this menace of cross border internet pharmacies, legitimate players are given specific operating licences that are shared with consumers, IIPA said, recommending a similar model for India.

    DCGIDrug Controller General of IndiaDrugs and Cosmetics Rulese-pharmacyIIPAIndian Internet Pharmacy AssociationIT ActPrashant Tandon
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok